Equitan Pediatric Interactions
There are 570 drugs known to interact with Equitan Pediatric (chlorpheniramine / phenylephrine / pyrilamine), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 39 are major, 528 are moderate, and 3 are minor.
- View all 570 medications that may interact with Equitan Pediatric
- View Equitan Pediatric alcohol/food interactions (2)
- View Equitan Pediatric disease interactions (11)
Most frequently checked interactions
View interaction reports for Equitan Pediatric (chlorpheniramine / phenylephrine / pyrilamine) and the medicines listed below.
- Ajovy (fremanezumab)
- albuterol
- Aspirin Low Strength (aspirin)
- azelastine nasal
- Botox (onabotulinumtoxinA)
- capsaicin topical
- diclofenac topical
- duloxetine
- famotidine
- fexofenadine
- fluticasone nasal
- Mapap (acetaminophen)
- mirtazapine
- montelukast
- Prevident 5000 Dry Mouth (fluoride topical)
- quetiapine
- Restasis (cyclosporine ophthalmic)
- rosuvastatin
- Senna-gen (senna)
- Spiriva Respimat (tiotropium)
- sumatriptan
- Symbicort (budesonide / formoterol)
- teriparatide
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Equitan Pediatric alcohol/food interactions
There are 2 alcohol/food interactions with Equitan Pediatric (chlorpheniramine / phenylephrine / pyrilamine).
Equitan Pediatric disease interactions
There are 11 disease interactions with Equitan Pediatric (chlorpheniramine / phenylephrine / pyrilamine) which include:
- depression
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- BPH
- diabetes
- glaucoma
Report options
More about Equitan Pediatric (chlorpheniramine / phenylephrine / pyrilamine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.